Lasev Pharma Consulting
Board
1 director, since incorporationDirector (not named in the articles)
since 12-09-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 29-04-2026
Mandates through the years
1 name, the dashed line is todayJASPART Séverine Francine Isabelle Ghislaine
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- JASPART Séverine Francine Isabelle Ghislaine
- Director (not named in the articles), from 12-09-2024 to date
Control
Founders
HUET Emmanuel Albert Jules, JASPART Séverine Francine Isabelle Ghislaine
This company
Lasev Pharma Consulting
Equity €68,160
Profit €53,920 in 2025
Capital
- Contribution
- €3,000
- Shares
- 100
- Contribution per share
- €30
- Equity per share
- €682 in 2025
- Source
- deed of 16-09-2024
Articles of association
deed of 16-09-2024 (in French)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director“À défaut d’indication de durée, le mandat sera censé conféré sans limitation de durée, ont seuls la direction des affaires sociales; chaque…”
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- 100 shares
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of June at 18:00
Shareholders
At incorporation
deed of 16-09-2024 ↗
- HUET Emmanuel Albert Jules 20 shares (20%) · in cash
- JASPART Séverine Francine Isabelle Ghislaine 80 shares (80%) · in cash